Targeting human prostatic carcinoma thro
β
Davol, Pamela A.; Frackelton, A. Raymond
π
Article
π
1999
π
John Wiley and Sons
π
English
β 462 KB
## BACKGROUND. Basic fibroblast growth factor receptors on DU145 human prostatic carcinoma xenografts serve as targets for the delivery of a growth factor-toxin chimera, basic fibroblast growth factor-saporin (bFGF-SAP), which produces significant antitumor activity in a nude mouse model. However,